Is this email not displaying correctly? View it in your browser.
January 2017
Institute for Clinical Evaluative Sciences
At a Glance: Monthly research findings straight to your inbox

ICES marks 25 years of research impact
Since the Institute for Clinical Evaluative Sciences (ICES) was established in 1992, our research has been presented in over 3,000 peer-reviewed papers. Click here to view an infographic with links to the 25 ICES papers that have been cited most often in the scientific literature over 25 years.

Single fathers depression
Click image to view interactive infographic with links to papers

Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study
Chen H, Kwong JC, Copes R, Tu K, Villeneuve PJ, van Donkelaar A, Hystad P, Martin RV, Murray BJ, Jessiman B, Wilton AS, Kopp A, Burnett RT. Lancet. 2017; Jan 4 [Epub ahead of print].

Pollution Study
Click image to enlarge

Inadequate screening for retinopathy among recent immigrants with type 2 diabetes despite universal health care: a population-based study
Lovshin JA, Shah BR. J Diabetes Complications. 2017; Jan 20 [Epub ahead of print].

Click image to enlarge

ICES research video series: Paul Kurdyak on ADHD rates and medication trends in Ontario

Hauck TS, Lau C, Wing LLF, Kurdyak P, Tu K. Can J Psychiatry. 2017; Jan 18 [Epub ahead of print].

Paul Kurdyak
Click image to play video

Variation in access to kidney transplantation across renal programs in Ontario, Canada
Naylor KL, Dixon SN, Garg AX, Kim SJ, Blake PG, Nesrallah GE, McCallum MK, D’Antonio C, Li AH, Knoll GA. Am J Transplant. 2017; Jan 9 [Epub ahead of print].

Click image to read news story

You may also be interested in...

Using the electronic medical record to identify patients at high risk for frequent ED visits and high system costs

Long-term clinical outcomes and predictors for survivors of out-of-hospital cardiac arrest

Effect of prepublication results on trends in prescribing of antihypertensive medication: impact of the ALTITUDE (Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Disease Endpoints) trial on aliskiren prescribing

Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement

Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization

Copyright © 2017 Institute for Clinical Evaluative Sciences, All rights reserved.